← The Wire
RLYBNasdaq
Rallybio Corp
Pharmaceutical Preparations · DE · CIK 1739410
Develops and commercializes life-transforming therapies for severe and rare diseases
red 8-K · 90d
$92M
Market cap
$16.06
Last close
+0.4%
1D
+0.8%
5D
31K
Volume
Price · last 39 sessions+13.7%
May 4L $14.00 · H $16.87Jun 29
92
Total filings
Jun 1, 2026
Last filing
12/31
Fiscal year end
8-KChange of Control · Executive ChangeJun 1, 20268-KAgreement TerminatedMay 4, 20268-KExecutive ChangeMar 31, 20268-KChange of Control · Executive ChangeMar 2, 20268-KBylaw Amendment · Shareholder VoteJan 29, 20268-KResults of OperationsNov 6, 20258-KDelisting NoticeAug 29, 20258-KResults of OperationsAug 7, 20258-KMaterial Agreement · Acquisition / DispositionJul 8, 20258-KExecutive ChangeJun 27, 20258-KShareholder VoteMay 16, 20258-KResults of OperationsMay 8, 20258-KCompany UpdateApr 8, 20258-KCompany UpdateMar 13, 20258-KResults of OperationsMar 13, 20258-KDelisting NoticeFeb 25, 20258-KResults of OperationsNov 7, 20248-KExecutive ChangeSep 17, 20248-KResults of OperationsAug 8, 20248-KExecutive ChangeJul 23, 20248-KShareholder VoteMay 21, 20248-KResults of OperationsMay 9, 20248-KMaterial Agreement · Equity IssuanceApr 10, 20248-KResults of OperationsMar 12, 20248-KResults of Operations · Exit / Disposal CostsFeb 6, 20248-KReg FD DisclosureDec 20, 20238-KResults of OperationsNov 9, 20238-KResults of OperationsAug 8, 20238-KExecutive ChangeJun 29, 20238-KShareholder VoteMay 22, 20238-KResults of OperationsMay 9, 20238-KResults of Operations · Reg FD DisclosureMar 6, 20238-KExecutive ChangeJan 31, 20238-KCompany UpdateDec 1, 20228-KMaterial Agreement · Company UpdateNov 14, 20228-KResults of OperationsNov 7, 20228-KReg FD DisclosureSep 28, 20228-KResults of OperationsAug 8, 20228-KExecutive Change · Reg FD DisclosureAug 2, 20228-KExecutive ChangeJun 2, 20228-KShareholder VoteMay 27, 20228-KMaterial Agreement · Results of OperationsMay 10, 20228-KExecutive Change · Reg FD DisclosureApr 4, 20228-KResults of OperationsMar 15, 20228-KReg FD DisclosureMar 7, 20228-KResults of OperationsNov 10, 20218-KResults of OperationsSep 9, 20218-KMaterial Agreement · Security-Holder RightsAug 2, 2021
Insider Activity
In the 90 days to Feb 23, 2026: 1 sold $4K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Lieber Jonathan IChief Financial Officer | Sell | 789 | $5.06 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance